Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.04. | Biotricity Inc.: Biotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed | 1 | GlobeNewswire (USA) | ||
12.03. | Biotricity expands intellectual property portfolio with 14 new patents | 1 | Seeking Alpha | ||
12.03. | Biotricity Inc.: Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management | 1 | GlobeNewswire (USA) | ||
21.02. | Biotricity GAAP EPS of -$0.05, revenue of $3.6M | 1 | Seeking Alpha | ||
20.02. | BIOTRICITY INC. - 10-Q/A, Quarterly Report | - | SEC Filings | ||
20.02. | Biotricity Inc.: Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025 | 145 | GlobeNewswire (Europe) | Company reports Q3-FY25 revenue grew by 21.7% YOY to $3.6 millionManagement continues to drive revenues and efficienciesCompany achieved positive cash flow on current operating basis, before paying... ► Artikel lesen | |
BIOTRICITY Aktie jetzt für 0€ handeln | |||||
19.02. | BIOTRICITY INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
17.02. | Biotricity expects to post Q3 revenue growth of 22%, cashflow breakeven | 2 | Seeking Alpha | ||
17.02. | Biotricity Inc.: Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11% | 149 | GlobeNewswire (Europe) | Company expects to report Q3-FY25 revenue growth of 22% from the corresponding prior year quarter to $3.6 million - an 11% increase sequentially from the immediately preceding quarterManagement continues... ► Artikel lesen | |
14.02. | BIOTRICITY INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
15.11.24 | Biotricity Inc.: Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025 | 169 | GlobeNewswire (Europe) | Company achieved positive cash flow in September on a current operating basis, before paying interest, dividends and amortization; management expects to continue to see cash flows improveCompany reports... ► Artikel lesen | |
10.10.24 | Delisting of Securities of Gamer Pakistan Inc.; Biotricity, Inc.; Zalatoris II Acquisition Corp.; Warrantee Inc.; Spectaire Holdings, Inc.; Centogene N.V.; DZS Inc.; Corner Growth Acquisition Corp. 2; Collective Audience, Inc.; Grom ... | 598 | GlobeNewswire (Europe) | NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Gamer Pakistan Inc. Gamer Pakistan Inc.'s securities were suspended on... ► Artikel lesen | |
03.10.24 | Biotricity, Inc.: Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins | 331 | ACCESS Newswire | The company has achieved EBIDTA positive on a go-forward cash basis REDWOOD CITY, CA / ACCESSWIRE / October 3, 2024 / Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company... ► Artikel lesen | |
26.09.24 | Biotricity, Inc.: Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States | 613 | ACCESS Newswire | REDWOOD CITY, CA / ACCESSWIRE / September 26, 2024 / Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with cutting-edge remote... ► Artikel lesen | |
19.09.24 | Biotricity, Inc.: Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals | 366 | ACCESS Newswire | REDWOOD CITY, CA / ACCESSWIRE / September 19, 2024 / Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with cutting edge remote... ► Artikel lesen | |
21.08.24 | Biotricity, Inc.: Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025 | 493 | ACCESS Newswire | The Company shows continued progress towards cash-flow break even and profitabilityRecurring Technology Fee (SaaS) revenue - over 94% of total revenue with a 76% gross margin, which rose over 400 basis... ► Artikel lesen | |
13.08.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.08.2024 | 663 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 13.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.08.2024ISIN NameCA44053J4090 HORIZON... ► Artikel lesen | |
22.07.24 | Biotricity, Inc.: Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud | 1.212 | ACCESS Newswire | REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced... ► Artikel lesen | |
19.07.24 | Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 446 | ACCESS Newswire | ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money... ► Artikel lesen | |
12.07.24 | Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 371 | ACCESS Newswire | ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ALPHATEC | 9,436 | -1,38 % | Alphatec Holdings, Inc. Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook | CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,840 | -0,28 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 48,050 | +1,18 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
FRESENIUS | 42,190 | +0,57 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.06.2025 /... ► Artikel lesen | |
PROGYNY | 21,460 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
PROCEPT BIOROBOTICS | 58,63 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 22,000 | +1,20 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
ADAPTHEALTH | 9,420 | +4,55 % | AdaptHealth Corp. - 10-K/A, Annual Report | ||
CARL ZEISS MEDITEC | 56,40 | -1,57 % | Aktienmarkt: Aktie von Carl Zeiss Meditec kann sich nicht behaupten (56,30 €) | Im deutschen Wertpapierhandel liegt die Carl Zeiss Meditec-Aktie gegenwärtig im Minus. Das Wertpapier kostete zuletzt 56,30 Euro. Ein Wertverlust in Höhe von 1,75 Euro müssen derzeit die Aktionäre von... ► Artikel lesen | |
GERRESHEIMER | 47,480 | +1,24 % | Deutsche Pfandbriefbank, Gerresheimer, Hugo Boss, Renk, Rheinmetall, Symrise - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
HIMS & HERS HEALTH | 39,700 | +0,35 % | Kein Wegovy mehr: Novo Nordisk bricht Partnerschaft: Hims & Hers-Aktie fällt ins Bodenlose! | © Foto: Christian Schultz/dpaNovo Nordisk bricht mit Hims & Hers: Beide Aktien fallen drastisch, wobei der Telemedizinanbieter aus den USA den Kürzeren zieht.Tiefschlag für die Anteilsscheine von Hims... ► Artikel lesen | |
PHETON | 17,540 | 0,00 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
RXSIGHT | 13,230 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
LIFEMD | 13,540 | 0,00 % | LifeMD-Aktie steigt nach Fortsetzung der Wegovy-Partnerschaft mit Novo Nordisk | ||
UNITEDHEALTH | 258,25 | -0,12 % | Dividendenbekanntmachungen (24.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPAGNIE DE L ODET SA FR0000062234 - 4,4 EUR DOM DEVELOPMENT SA PLDMDVL00012 7 PLN 1,6374 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen |